5-ALA-PDT induced ferroptosis in keloid fibroblasts via ROS, accompanied by downregulation of xCT, GPX4
- Photodiagnosis Photodyn Ther. 2023 May 21;103612. doi: 10.1016/j.pdpdt.2023.103612.
- 1. Department of Plastic and Cosmetic Surgery, Daping Hospital, Army Medical University, Chongqing, China.
- 2. Bioengineering College of Chongqing University, Chongqing, China.
- 3. Department of Dermatology, Daping Hospital, Army Medical University, Chongqing, China.
- 4. Department of Dermatology, Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- 5. Department of Urology, Daping Hospital, Army Medical University, Chongqing, China.
- 6. Department of Plastic and Cosmetic Surgery, Daping Hospital, Army Medical University, Chongqing, China. Electronic address: [email protected].
- 7. Department of Plastic and Cosmetic Surgery, Daping Hospital, Army Medical University, Chongqing, China. Electronic address: [email protected].
Keloids display many cancerous properties, including uncontrolled and invasive growth, high rates of recurrence as well as similar bioenergetics. 5-aminolevulinic acid-based photodynamic therapy (5-ALA-PDT) is an effective treatment that performs cytotoxic effects by producing Reactive Oxygen Species (ROS), which is linked to lipid peroxidation and Ferroptosis. Herein, we explored underlying mechanisms of 5-ALA-PDT against keloids. We identified that 5-ALA-PDT led to elevated levels of ROS and lipid peroxidation in keloid fibroblasts, accompanied by downregulation of xCT and GPX4, which are associated with anti-oxidation effects and Ferroptosis inhibition. These results may indicate that 5-ALA-PDT treatment increases ROS while inhibiting xCT and GPX4, thus promoting lipid peroxidation to induce Ferroptosis in keloid fibroblasts.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Cancer
-
Research Areas: Cancer
-
target: Reactive Oxygen Species (ROS)